IL1B and Alzheimer disease: Furthermore, improvement in cognitive function with neuroprotectants (e.g., CDL-choline) [31–33] or vegetal neurotrophins (e.g., anapsos) [34, 35] can reverse alterations in HA, TNF-α, and IL-1β levels in AD and in animal models of dementia [7, 25, 34–37].